Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Stewart Murray Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 4 Stewart Murray (Interim Chief Medical Officer) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Granted 269,893 shares @ $0
Sold 130,056 shares @ $1.06, valued at $137.9k
01/12/2023 4 Stewart Murray (Director) has filed a Form 4 on AMARIN CORP PLC\UK
Txns: Granted 223,560 options to buy @ $1.48, valued at $330.9k
Granted 182,433 options to buy @ $0
01/12/2023 3 Stewart Murray (Director) has filed a Form 3 on AMARIN CORP PLC\UK
06/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2020 4 Stewart Murray (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Granted 10,000 options to buy @ $7.27, valued at $72.7k
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2020 4 Stewart Murray (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Granted 3,427 options to buy @ $8.69, valued at $29.8k
02/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2019 4 Stewart Murray (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc
Txns: Granted 6,854 options to buy @ $17.41, valued at $119.3k
04/02/2019 3 Stewart Murray (Director) has filed a Form 3 on X4 Pharmaceuticals, Inc
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
02/14/2018 4 Stewart Murray (Executive Vice President, R&D) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 45,000 options to buy @ $0
11/29/2017 4 Stewart Murray (Executive Vice President R&D) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 50,000 shares @ $0
Granted 200,000 options to buy @ $0
11/29/2017 3 Stewart Murray (Executive Vice President, R&D) has filed a Form 3 on NOVELION THERAPEUTICS INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy